Edition:
United Kingdom

Allena Pharmaceuticals Inc (ALNA.OQ)

ALNA.OQ on NASDAQ Stock Exchange Global Select Market

10.21USD
22 Oct 2018
Change (% chg)

-- (--)
Prev Close
$10.21
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
28,069
52-wk High
$17.55
52-wk Low
$6.15

Chart for

About

Allena Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing non-systemic oral protein therapeutics to treat metabolic and orphan diseases, with a particular focus on nephrologic and urologic conditions. Its lead product candidate, ALLN-177, is in an ongoing Phase II... (more)

Overall

No Ratios Available.

Financials

  ALNA.OQ Industry Sector
P/E (TTM): -- 85.35 33.64
EPS (TTM): -- -- --
ROI: -- 0.18 14.27
ROE: -- 1.14 15.99

BRIEF-Allena Pharmaceuticals Reports Q1 Loss Per Share $0.38

* ALLENA PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

08 May 2018

Earnings vs. Estimates